AgomAb Therapeutics (AGMB) IPO deck
AgomAb Therapeutics developed disease-modifying therapies targeting chronic fibrotic and inflammatory disorders.
AgomAb Therapeutics developed disease-modifying therapies targeting chronic fibrotic and inflammatory disorders.
%20IPO%20deck){kind=link}